baber/WOPTO huggingface dataset:
Patent FI-20001488-A0 (FI)
Inventor: VATANEN HARRI
IPC: H04L12/56
Filed: 2000-06-21
Abstract: A method and system for the handling of a transaction request sent to a server from a terminal device over a telecommunication network, where the transaction request includes identifying data of the requester, identifying data of a utilized network component, and the digital signature of the requester. In response to the transaction request, a transaction message is sent from the server to the terminal device and/or to identified utilized network component. Message-type data and subscriber data are appended to the transaction message before it is sent by the server. The appended message-type data and subscriber data are then extracted from the transaction message in the telecommunication network and are used as handling data for carrying out and otherwise in connection with the transaction.
Patent FI-20011359-A0 (FI)
Inventor: TUOMELA TEEMU
IPC: H04L12/56
Filed: 2001-06-25
Abstract: Bluetooth relay devices can be used for networking different Bluetooth devices. Such relay devices typically have many Bluetooth modules, each of which can communicate with a number of different Bluetooth devices and/or adjacent relay devices. In order to avoid transmitting by one Bluetooth module of a relay device whilst its another Bluetooth module receives, all the Bluetooth modules of the relay device are set as masters and one of them is given control over the others so as to enforce all the Bluetooth modules to time their receptions so that no simultaneous transmissions by another Bluetooth modules occur. <IMAGE>
Patent IL-102716-A0 (IL)
Title: Nitrogen-based stabilizers for 3-isothiazolones
IPC: C07D213/06
Filed: 1992-08-03
Abstract: A method of protecting 3-isothiazolones of the formula: <CHEM>  wherein Y is (C1-C18)alkyl or (C3-C12)cycloalkyl each optionally substituted with one or more of hydroxy, halo, cyano, alkylamino, dialkylamine, arylamino, carboxy, carbalkoxy, alkoxy, aryloxy, alkylthio, arylthio, haloalkoxy, cycloaklylamino, carbamoxy, or isothiazolonyl; an unsubstituted or halo-substituted (C2-C8) alkenyl or alkynyl; a (C7-C10)aralkyl optionally substituted with one or more of halogen, (C1-C4)alkyl or (C1-C4)alkoxy; and an aryl optionally substituted with one or more of halogen, nitro, (C1-C4)alkyl, (C1-C4)alkyl-acylamino, carb(C1-C4)alkoxy or sulfamyl; and R and R<1> is each independently H, halogen (C1-C4) alkyl, (C4-C8) cycloalkyl or joined together to form a phenyl; comprising incorporating therewith an effective amount of a nitrogen-containing, sulphur-free compound, capable of reversibly associating with said isothiazolone.
Patent IL-107460-A0 (IL)
Title: Controlled cryogenic contact system
IPC: F25B9/02
Filed: 1993-11-01
Abstract: An apparatus for creating controlled temperature changes on a contact surface, comprises: a) a probe having a contact surface, which probe is suitable for creating fast temperature changes at the said contact surface; b) temperature generation means, coupled to the said probe, being capable of creating cryogenic and above 0 DEG C temperatures at the said contact surface of the said probe; and c) processing means to control the said temperature generation means according to predetermined operating conditions. <IMAGE>
Patent IL-113179-A0 (IL)
Title: Rapamycin hydroxyesters and pharmaceutical compositions containing them
IPC: A61K31/00
Filed: 1995-03-29
Abstract: A compound of structure (I)   
wherein R 1  and R 2  are each, independently, hydrogen or - CO(CR 3 R 4 ) b (CR 5 R 6 ) d CR 7 R 8 R 9  ; 
R 3  and R 4  are each, independently, hydrogen, alkyl, alkenyl, alkynyl, trifluoromethyl, or -F; 
R 5  and R 6  are each, independently, hydrogen, alkyl, alkenyl, alkynyl, -(CR 3 R 4 ) f OR 10 , -CF 3 , -F, or -CO 2 R 11 , or R 5  and R 6  may be taken together to form X or a cycloalkyl ring that is optionally mono-, di-, or tri-substituted with - (CR 3 R 4 ) f OR 10 ; 
R 7  is hydrogen, alkyl, alkenyl, alkynyl, -(CR 3 R 4 ) f OR 10 , -CF 3 , -F, or -CO 2 R 11 ; 
R 8  and R 9  are each, independently, hydrogen, alkyl, alkenyl, alkynyl, -(CR 3 R 4 ) f OR 10 , -CF 3 , -F, or -CO 2 R 11 , or R 8  and R 9  may be taken together to form X or a cycloalkyl ring that is optionally mono-, di-, or tri-substituted with -(CR 3 R 4 ) f OR 10 ; 
R 10  is hydrogen, alkyl, alkenyl, alkynyl, tri-(alkyl)silyl, tri-(alkyl)silylethyl, triphenylmethyl, benzyl, alkoxymethyl, tri-(alkyl)silylethoxymethyl, chloroethyl, or tetrahydropyranyl; 
R 11  is hydrogen, alkyl, alkenyl, alkynyl, or phenylalkyl; 
X is 5-(2,2-dialkyl)[1,3]dioxanyl, 5-(2,2-dicycloalkyl)[1,3]dioxanyl, 4-(2,2-dialkyl)[1,3]-dioxanyl, 4-(2,2-dicycloalkyl)[1,3]dioxanyl, 4-(2,2-dialkyl)[1,3]dioxalanyl, or 4-(2,2-dicycloalkyl)[1,3]dioxalanyl; 
b = 0-6; 
d = 0-6; and 
f = 0-6 
with the proviso that R 1  and R 2  are both not hydrogen and further provided that either R 1  or R 2  contains at least one -(CR 3 R 4 ) f OR 10 , X, or -(CR 3 R 4 ) f OR 10  substituted cycloalkyl group, or a pharmaceutically acceptable salt thereof which is useful as an immunosuppressive, antiinflammatory, antifungal, antiproliferative, and antitumor agent.
Patent IL-113360-A0 (IL)
Title: Lobaplatin trihydrate, its preparation and pharmaceutical compositions containing it
IPC: A61K31/555
Filed: 1995-04-13
Abstract: Cis-[trans-1,2-cyclobutanebis (methylamine)-N,N']-[(2S)-lactate-O1,O2)-platinum (II) trihydrate (lobaplatin trihydrate) and its preparation.
Patent IL-115562-A0 (IL)
Title: Production of sucralose
IPC: C07H5/02
Filed: 1995-10-11
Abstract: A process is claimed for producing sucralose, i.e. 4,1',6'-trichloro-4,1',6'-trideoxygalactosucrose of formula (I), from a feed mixt. contg. (a) 6-O-acyl-sucralose (II), (b) salt including alkali metal or alkaline earth metal chloride, (c) water and (d) other chlorinated sucrose by-products, in a reaction medium contg. a tert. amide (III). The process involves: (i) deacylating (II) by raising the pH of the mixt. to 10-12, to give an aq. mixt. contg. (I), (b), (d) and (III); (ii) removing (III); and (iii) recovering (I) from the product. Alternatively the process involves: (i') removing (III) to give an aq. soln. of (II), (b) and (d) from which a major proportion of the (III) in the feed mixt. has been removed; (ii') deacylating as in (i), to give an aq. soln. contg. (I), (b) and (d); and (iii') recovering (I) from the product.
Patent IL-124831-A0 (IL)
Title: Ob protein derivatives having prolonged half-life
IPC: C12N5/10
Filed: 1996-12-19
Abstract: The present invention concerns long half-life derivative of the obesity protein OB. The invention specifically concerns OB protein-immunoglobulin chimeras and polyethylene glycol (PEG)-OB derivatives, which have extended half-life as compared to the corresponding native OB proteins. The invention further relates to methods for appetite and/or weight reduction and for treating other physiological conditions by using the long half-life derivatives of OB.
Patent IL-126910-A0 (IL)
Title: Supporting frame with assemblage nodes and braces
IPC: F16B12/00
Filed: 1997-12-16
Abstract: The invention relates to a supporting frame with assemblage nodes and braces, which is characterized in that the joint between the assemblage nodes (3) and the end parts (27) of the braces (5) comprises a pin joint, that at least one of the elements (braces (5)) of the pin joint (11) which can be plugged into each other has at least one magnet (29), and that at least a partial area of the corresponding counter-part (pin (13)) is ferromagnetic.
Patent IL-130797-A0 (IL)
Title: Hard gelatine capsules containing pharmaceutical compositions substantially free of any oil
IPC: A61K9/107
Filed: 1998-01-28
Abstract: The present invention provides a hard gelatine capsule containing a pharmaceutical composition comprising cyclosporin A, a surfactant of HLB value of at least 10 comprising a polyoxyethylene-sorbitan-fatty acid ester and/or a sorbitan fatty acid ester, and a hydrophilic phase comprising a polyethylene glycol and at least one lower alkanol, wherein each lower alkanol present is present in an amount of less than 12 % of the total weight of the composition disregarding the hard gelatine capsule, the composition being substantially free of any additional oil.
Patent IL-134138-A0 (IL)
Title: System and method for synchronizing electronic mail across a network
IPC: H04L12/58
Filed: 1998-07-21
Abstract: A system (800) includes an e-mail engine which uses a proper protocol to retrieve an e-mail (875) from a first mail store (850) and to store the e-mail (875) in one or more folder structures (138, 140, 142, 144). Upon request, the first mail store (850) may send configuration data indicating the proper protocol to the e-mail engine, which can then properly configure itself. An e-mail synchronization module (885) uses a predetermined criterion to determine whether the e-mail (875) was previously sent and whether to synchronize the e-mail (875) with a second mail store (895). The e-mail synchronization module (885) may also synchronize the e-mail to specified folder structures. The second mail store (895) may be located on a global server (830), which upon proper identification and authentication provides roaming users (805) with access to its contents. A communications module establishes a communications channel through any firewalls (880) with the second mail store. A web engine (890) sends the e-mail via the communications channel to the second mail store (895).
Patent IL-140651-A0 (IL)
Title: Cells and animals deficient in protein kinase c epsilon
Inventor: HODGE CLYDE W
IPC: A01K67/027
Filed: 1999-07-02
Abstract: The present invention is directed to the production of PKC isozyme epsilon (PKCepsilon)-deficient cells and non-human animals. The present invention is further directed to the identification of PKCepsilon as a target for drugs that reduce anxiety. According to the present invention, PKCepsilon-inhibiting compounds act in synergy with drugs acting at the GABAA receptor. The present invention is also directed to the use of modulators of PKCepsilon to modulate alcohol consumption, self-administration of other drugs of abuse, and the effects of alcohol consumption as well as the use of inhibitors of PKCepsilon, either alone or in conjunction with allosteric agonists of GABAA receptors, to treat conditions, such as addiction, withdrawal syndrome, skeletal muscle spasms, convulsive seizures, and epilepsy, that are amenable to treatment by allosteric agonists of GABAA receptors. Additional aspects of the present invention are diagnostic methods for identifying individuals at risk for becoming alcoholics or abusers of other drugs and kits for performing such diagnostic methods. The present invention relates to: cells and non-human animals deficient for the PKC isozyme epsilon (PKCepsilon); the use of PKCepsilon as a target for drugs; the use of inhibitors of PKCepsilon in methods of reducing anxiety and treating conditions associated with insufficient activity of the GABAA receptor; the use of modulators of PKCepsilon in methods of modulating alcohol consumption, modulating self-administration of other drugs of abuse, and altering the effects of alcohol; pharmaceutical compositions comprising inhibitors of PKCepsilon and allosteric agonists of GABAA receptors; and the identification of individuals with enhanced susceptibility to alcoholism or other forms of addiction.
Patent IL-141116-A0 (IL)
Title: Submersed device for reducing the polluting emissions and saving energy in hydrocarbon combustion vehicles
IPC: F02M27/04
Filed: 1999-07-26
Abstract: A device submersed into the fuel tank of motor vehicles with liquid-hydrocarbon internal-combustion engines for reducing polluting emissions and saving energy, characterized in that there are generated, in combination, magnetic fields and far infrared electromagnetic waves which spread inside the fuel and interact with the molecules of the hydrocarbons and temporarily modify their structure so that they can be easily vaporized. This temporary modification of the hydrocarbons' molecular structure is obtained by energising said molecules through the energy associated to said far infrared rays under the action of said magnetic fields.
Patent IL-142596-A0 (IL)
Title: Baculovirus expression system
IPC: C07K14/01
Filed: 2000-08-14
Abstract: Described herein are baculovirus vectors, host cells containing the baculovirus vectors, methods of using the baculovirus vectors for cloning genes, and kits containing the baculovirus vectors.
Patent IL-144298-A0 (IL)
Title: Flexible heart valve
IPC: A61F2/24
Filed: 2000-01-26
Abstract: A prosthetic heart valve (40) for implant at an aortic annulus, comprising: 
an elongate rod-like flexible stent (46, 250, 280, 290, 300, 310, 320) having alternating inflow cusps (60) and outflow commissures (62) made of an elastic material; 
a plurality of flexible leaflets (42) attached to the stent so as to form a one-way valve within the stent; and 
a suture-permeable connecting band (48) attached to the stent providing an interface between the valve and surrounding host tissue, wherein the connecting band shape mimics the alternating stent cusps and commissures and provides a flexible interface for suturing that conforms to a natural aortic root, and 
wherein the flexible stent is relatively more rigid than the leaflets and connecting band and acts to limit total flexibility of the valve, and wherein the stent is flexible to permit the cusps to move radially relative to each other about the commissures, and wherein the connecting band defines axial gaps (142) opening in the inflow direction between the cusps of the stent to minimize interference with pivoting movement of the stent cusps.
Patent IL-148904-A0 (IL)
Title: Amino substituted pyrazolo {1,5,-a}-1,5- pyrimidines and pyrazolo{1,5,-a}-1,3,5-triazines
IPC: A61P25/08
Filed: 2000-09-29
Abstract: Disclosed are compounds of the formula:where R1, R2, R3, R4, R5, R6, and X are defined herein. These compounds are selective modulators of NPY1 receptors. These compounds are useful in the treatment of a number of CNS disorders, metabolic disorders, and peripheral disorders, particularly eating disorders and hypertension. Methods of treatment of such disorders and well as packaged pharmaceutical compositions are also provided.Compounds of the invention are also useful as probes for the localization of NPY1 receptors and as standards in assays for NPY1 receptor binding. Methods of using the compounds in receptor localization studies are given.
Patent IL-154406-A0 (IL)
Title: Method for precision rending of a sheet of material and slit sheet therefor
IPC: B21D5/00
Filed: 2001-08-16
Abstract: A method of slitting and bending an elastically and plastically deformable sheet of material comprising the steps of:  forming two elongated slits through the sheet of material with each slit being laterally offset on opposite sides of a desired bend line and being longitudinally displaced relative to the other slit along said bend line, said slits having a kerf width dimensioned to produce interengagement of edges of said sheet of material on opposite sides of said slits during bending; and  bending said sheet of material about a virtual fulcrum aligned with said bend line to produce plastic and elastic deformation of said sheet of material along said bend line and interengagement of said edges.
Patent IL-156535-A0 (IL)
Title: Pool cleaning apparatus
IPC: E04H4/16
Filed: 2003-06-19
Abstract: A system for determining the effectiveness of the filtering and maneuverability of a robot for cleaning swimming pools, said robot including a robot propelling motor, at least one water pump having an impeller and an impeller motor, a pool water inlet leading to a filter, a filtered water outlet, and means for propelling said robot along the floor and/or walls of said swimming pool, said system comprising:  computer means for determining and setting an initial power to be supplied to said impeller motor; first circuit means for sensing the actual power supplied to said impeller motor during its operation; second circuit means for calculating the ratio between the set power and an instantaneous power supplied to said impeller motor, and means connected to said second circuit means for producing an indication signal when said ratio exceeds a predetermined value.  <IMAGE>
Patent IL-161499-A0 (IL)
Title: Container for dispensing spill-resistant formulations
IPC: B65D51/18
Filed: 2002-10-22
Abstract: An article of manufacture comprises a) a squeezable bottle having an outlet, b) a plug in the bottle, the plug comprising an upper surface with a protruding nipple having a neck, and a top and an orifice communicating with a smooth tubular channel sized to permit a semi-solid formulation to be squeezed out of the bottle and through the channel and orifice without dislodging the cap, the neck of the nipple having a protruding height slightly greater than the thickness of a spoon, and the neck of the nipple and the flat upper surface forming a notch which engages with the edge of a spoon, the orifice forming a sharp intersection with the top of the nipple sufficient to cut flow of the formulation cleanly when pressure ceases, and the junction of the top of the nipple with the nipple neck having a bevel, and c) a child resistant cap to cover the orifice when the formulation is not in use, the cap sealing the orifice without abrading the nipple.
Patent IL-165149-A0 (IL)
Title: Process for producing a lactose-free milk product
IPC: A23C9/142
Filed: 2004-11-10
Abstract: The invention relates to a process for producing lactose-free milk products. The process of the invention is characterized by the steps of subjecting a milk product to ultrafiltration (UF), nonfiltration (NF) and concentration by reverse osmosis, followed by the addition of salt to the UF retentate.
Patent IL-169703-A0 (IL)
Title: Methods for preparing aqueous colored pigment dispersions and inkjet ink compositions
IPC: C09D17/00
Filed: 2005-07-17
Abstract: The present invention describes methods for preparing aqueous colored pigment dispersions comprising the step of combining, in any order, a) a colored pigment, b) an azo coupler, c) an aromatic amine, d) a diazotizing agent, and e) an aqueous medium, wherein the aromatic amine comprises as least one ionic group, at least one ionizable group, or a mixture of at least one ionic group and at least one ionizable group. These colored pigment dispersions are particularly useful as an inkjet ink composition. Also disclosed are inkjet ink compositions comprising a) a liquid vehicle, b) a colored pigment, and c) a dispersant having the formula: <?in-line-formulae description="In-line Formulae" end="lead"?>D-N-N-AC,<?in-line-formulae description="In-line Formulae" end="tail"?> wherein AC is an azo coupling component and D is a diazo component comprising at least one ionic group, at least one ionizable group, or a mixture of at least one ionic group or ionizable group.
Patent RO-130982-A0 (RO)
Title: Connection pieces for a metallic construction structure
Inventor: ZAHIU LAURENŢIU VALENTIN
IPC: E04B1/24
Filed: 2015-11-17
Abstract: The invention relates to some connection pieces for a metallic construction structure, such as industrial or house construction. According to the invention, the connection pieces for a metallic construction structure consist of a fixing box (3), provided at the lower side of some metallic poles (1), a double symmetrical connection box (5), which is introduced half into the lower metallic poles (1), and half into the upper metallic poles (1), end connection boxes (7) provided on the ends of some metallic beams (2), which provide the connection between the metallic poles (1) and the metallic beams (2).
Patent MA-55635-A1 (MA)
Title: Un dispositif pour reduire la propagation du dioxyde de carbone dans l'atmosphere
Inventor: AYOUB BELLEFKIH
IPC: B01D53/62
Filed: 2022-02-09
Abstract: Cette invention concerne une machine en forme de cylindre contenant un filtre en aluminium, à l'intérieur duquel se trouve un réseau de pièces en aluminium relié à un refroidisseur, à l'intérieur duquel se trouve un tube sur lequel se gèle uniquement le dioxyde de carbone, un capteur qui donne un signal de sa plénitude, et deux moteurs qui font passer la température (-80° c) et le reste des gaz continuent à sortir sous forme de vapeur.
Patent UY-23465-A1 (UY)
Title: Articulos solidos configurados reforzados con fibra
Inventor: LHONEUX BENOIT DE
IPC: E04C5/07
Filed: 1992-08-28
Abstract: La presente invención se refiere a un artículo sólido configurado manufacturado con una composición hidraulicamente endurecible que comprende agua, ligantes hidráulicos y fibras de refuerzo y además fibras de proceso en una cantidad de 0-10% por peso con respecto a la mezcla seca total y materiales de carga en una cantidad de 0-50% por peso con respecto a la mezcla seca total, caracterizado en que las fibras de refuerzo comprenden de 0.1-5% por peso con respecto a la mezcla total seca de fibras de polipropileno elevadamente cristalinas que poseen una resistencia al rompimiento de las fibras de sobre 490 N/mm2, teniendo una -- Q<5 y 97<HI<100, y 94<IPF<100, en donde Q es la relación de peso molecular de peso promedio al peso molecular del número promedio, HI es el contenido de n-heptano insoluble de ebullición en % por peso con respecto al polímero total e IPF es la fracción pentada isotáctica en mol%.
Patent UY-24504-A1 (UY)
Title: Dihidrato de eprosartano y un procedimiento para su produccion y formulacion
Inventor: PALEPU Nageswara
IPC: A61K31/401
Filed: 1997-03-26
Abstract: Un procedimiento para la preparación de un compuesto que es dihidrato de monometanosulfonato de ácido (E)-alfa-[2-n-butil-1-[(4-carboxifenil)metil]-1H-imidazol-5-il]metilen-2-tiofenopropiónico; que comprende recristalizar la forma anhidra de monometansulfonato de ácido (E) )-alfa-[2-n-butil-1-[(4-carboxifenil)metil]-1H-imidazol-5-il]metilen-2-tiofenopropiónico en una solución acuosa que contiene un ácido. El procedimiento para la preparación de dihidrato de eprosartano que comprende: a- suspender anhidrato de eprosartano en una solución acuosa de ácido metanosulfónico3,0 M; b- agitar continuamente la suspensión y calentar a 65-70ºC; c- filtrar y mantener el filtrado obtenido a 75ºC durante varios minutos para garantizar la ausencia del anhidrato en solución; d- enfriar lentamente la solución a temperatura ambiente, y; e- filtrar, recoger la sustancia cristalina, incolora, clara y dejar secar al aire. El producto de la invención es útil para bloquear los receptores de la angiotesina II y para tratar la hipertensión, la insuficiencia cardiaca congestiva y la insuficiencia renal.
Patent UY-28317-A1 (UY)
Title: Compuestos útiles para el tratamiento de enfermedades
Inventor: GLOSSOP PAUL ALAN
IPC: C07D217/06
Filed: 2004-05-12
Abstract: La invención se refiere a compuestos de fórmula (1) y a procesos para la preparación de tales derivados, a intermedios usados en su preparación, a composiciones que los contienen y a los usos de tales derivados. Los compuestos de acuerdo con la presenten invención son útiles en numerosas enfermedades, trastornos y afecciones, en particular enfermedades trastornos y afecciones inflamatorios, alérgicas y respiratorias.
Patent UY-29800-A1 (UY)
Title: Método para control genético de infestaciones por insectos en plantas, y composiciones derivadas
Inventor: BAUM JAMES A
IPC: A23L7/10
Filed: 2006-09-18
Abstract: La presente invención se refiere al control de infestación por pestes mediante la inhibición de una o más funciones biológicas. La invención proporciona métodos y composiciones para tal control, mediante alimentación a la peste con una o más moléculas de ARN bicatenario recombinante provistas por la invención; una reducción en la infestación por peste se obtiene por la supresión del gen de expresión. La invención también se dirige a métodos para fabricar plantas transgénicas que expresan las moléculas de ARN bicatenaria, y a particulares combinaciones de agentes pesticidas transgénicos para uso en la protección de las plantas infestadas.